Ectopic expression of toll-like receptor-3 (TLR-3) overcomes the double-stranded RNA (dsRNA) signaling defects of P2.1 cells

Journal of Interferon and Cytokine Research

Volumn 24, Issue 6, 2004, Pages 350-361

  Sun, Yaping ^a   Leaman, Douglas W ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 9 [3 (2 CHLOROETHYL)AMINOPROPYLAMINO] 2 METHOXYACRIDINE; BETA INTERFERON; DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCALATING AGENT; INTERFERON REGULATORY FACTOR 1; JANUS KINASE; TOLL LIKE RECEPTOR 3;

ARTICLE; CELL MUTANT; CONTROLLED STUDY; DNA MICROARRAY; FIBROSARCOMA; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SARCOMA CELL; SIGNAL TRANSDUCTION; VIRUS INFECTION; WILD TYPE;

APOPTOSIS; CELL LINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; MEMBRANE GLYCOPROTEINS; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTORS;

JANUS;

EID: 2942678697     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999004323142213     Document Type: Article

References (27)

1. JACOBS, B.L., and LANGLAND, J.O. (1996). When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219, 339-349.
2. GUIDOTTI, L.G., and CHISARI, F.V. (2001). Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65-91.
3. STARK, G.R., KERR, I.M., WILLIAMS, B.R., SILVERMAN, R.H., and SCHREIBER, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
4. GEISS, G., JIN, G., GUO, J., BUMGARNER, R., KATZE, M.G., and SEN, G.C. (2001). A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling J. Biol. Chem. 276, 30178-30182.
5. VILCEK, J., and SEN, G.C. (1996). Interferons and other cytokines. In: Fields Virology. 3rd ed. B.N. Fields, D.M. Knipe, and P.M. Howley (eds.) Philadelphia: Lippincott-Raven Publishers, pp. 375-399.
6. TIWARI, R.K., KUSARI, J., and SEN, G.C. (1987). Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors. EMBO J. 6, 3373-3378.
7. BANDYOPADHYAY, S.K., LEONARD G.T., Jr., BANDYOPADHYAY, T., STARK, G.R., and SEN, G.C. (1995). Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. J. Biol. Chem. 270, 19624-19629.
8. WEAVER, B.K., KUMAR, K.P., and REICH, N.C. (1998). Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18, 1359-1368.
9. DOYLE, S., VAIDYA, S., O'CONNELL, R., DADGOSTAR, H., DEMPSEY, P., WU, T., RAO, G., SUN, R., HABERLAND, M., MODLIN, R., and CHENG, G. (2002). IRF3 mediates a TLR3/ TLR4-specific antiviral gene program. Immunity 17, 251-263
10. AKIRA, S., and HEMMI, H. (2003). Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85, 85-95.
11. ALEXOPOULOU, L., HOLT, A.C., MEDZHITOV, R., and FLAVELL, R.A. (2001). Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3. Nature 413, 732-738.
12. MATSUMOTO, M., KIKKAWA, S., KOHASE, M., MIYAKE, K., and SEYA, T. (2002). Establishment of a monoclonal antibody against human toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293, 1364-1369.
13. DIEBOLD, S.S., MONTOYA, M., UNGER, H., ALEXOPOULOU, L., ROY, P., HASWELL, L.E., ALSHAMKHANI, A., FLAVELL, R., BORROW, P., REIS, E., and SOUSA, C. (2003). Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424, 324-328.
14. LEAMAN, D.W., SALVEKAR, A., PATEL, R., SEN, G.C., and STARK, G.R. (1998). A mutant cell line defective in response to double-stranded RNA and in regulating basal expression of interferon-stimulated genes. Proc. Natl. Acad. Sci. USA 95, 9442-9447.
15. PELLEGRINI, S., JOHN, J., SHEARER, M., KERR, I.M., and STARK, G.R. (1989). Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9, 4605-4612.
16. PETERS, K.L., SMITH, H.L., STARK, G.R., and SEN, G.C. (2002). IRF3-dependent, NF-kappaB-and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc. Natl. Acad. Sci. USA 99, 6322-6327.
17. McKENDRY, R., JOHN, J., FLAVELL, D., MULLER, M., KERR, I.M., and STARK, G.R. (1991). High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Pro. Natl. Acad. Sci. USA 88, 11455-11459.
18. MULLER, M., BRISCOE, J., LAXTON, C., GUSCHIN, D., ZIEMIECKI, A., SILVENNOINEN, O., HARPUR, A.G., BARBIERI, G., WITTHUHN, B.A., SCHINDLER, C., PELLEGRINI, S., WILKS, A.F., IHLE, J.N., STARK, G.R., and KERR, I.M. (1993). The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366, 129-135.
19. BALDWIN, A.S., Jr., and SHARP, P.A. (1988). Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class 1 major histocompatibility complex promoter. Proc. Natl. Acad. Sci. USA 85, 723-727.
20. LI, M., SHILLINGLAW, W., HENZEL, W.J., and BEG, A.A. (2001). The Rel A (p65) subunit of NF-kappa B is essential for inhibiting double-stranded RNA-induced cytotoxicity. J. Biol. Chem. 276, 1185-1194.
21. CHAWLA-SARKAR, M., LEAMAN, D.W., JACOBS, B.S., and BORDEN, E.C. (2002). IFN-β pretreatment sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) induced apoptosis. J. Immunol. 169, 847-855.
22. LEAMAN, D.W., CHAWLA-SARKAR, M., SUN, Y., VYAS, K., OZDEMIR, A., YI, T., and BORDEN, E.C. (2003). Identification of growth and death related interferon (IFN) stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared to IFN-alpha. J. Interferon Cytokine Res. 23, 745-756.
23. O'NEILL, L.A., FITZGERALD, K.A., and BOWIE, A.G. (2003). The toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24, 286-290.
24. JANSSENS, S., and BEYAERT, R. (2003). Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family member. Mol. Cell 11, 293-302.
25. BARBER, G.N. (2001). Host defense, viruses and apoptosis. Cell Death Differ. 8, 113-126.
26. GRANDVAUX, N., SERVANT, M.J., TENOEVER, B., SEN, G.C., BALACHANDRAN, S., BARBER, G.N., LIN, R., and HISCOTT, J. (2002). Transcriptional profiling of interferon regulatory factor-3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76, 5532-5539.
27. DER, S.D, ZHOU, A., WILLIAMS, B.R.G., and SILVERMAN, R. (1998). Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95, 15623-15628.